HF
TNYA icon

HRT Financial’s Tenaya Therapeutics TNYA Stock Holding History

HRT Financial’s Portfolio TNYA Stock Details TNYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9K Buy
+12,251
New +$9.3K ﹤0.01% 3996
2025
Q3 		– Sell
-34,310
Closed -$20K – 3677
2025
Q2 		$20K Buy
+34,310
New +$17.5K ﹤0.01% 2401
2023
Q4 		– Sell
-12,018
Closed -$30K – 3088
2023
Q3 		$30K Buy
+12,018
New +$50.3K ﹤0.01% 2037

Other funds holding TNYA

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EAM
Empery Asset Management New York $86.5M AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
BGM
Burkehill Global Management New York $2.77B AUM 65.75% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

HRT Financial's TNYA Position: Q2 2026 in Review

HRT Financial opened a new position in Tenaya Therapeutics (TNYA) in Q2 2026: 12,251 shares worth $9K. The stake represents ﹤0.01% of the portfolio and ranks #3996 among its holdings. This is a return to the name: HRT Financial previously reported a position in TNYA as recently as Q2 2025.

HRT Financial first reported a position in TNYA in Q3 2023 and has held it in 3 quarters since. The position peaked at $30K in Q3 2023. 101 funds tracked by Wall St. Rank hold TNYA as of Q2 2026.

  • HRT Financial held 12,251 shares of Tenaya Therapeutics worth $9K as of Q2 2026.
  • Tenaya Therapeutics was a new HRT Financial position in Q2 2026.
  • Tenaya Therapeutics made up ﹤0.01% of HRT Financial's portfolio in Q2 2026, its #3996 holding.
  • HRT Financial first reported a position in Tenaya Therapeutics in Q3 2023 and has held it in 3 quarters since.
  • HRT Financial's Tenaya Therapeutics position peaked at $30K in Q3 2023.
  • 101 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.